Effect of irinotecan hydrochloride injection on serum GPX3 and WISP2, FGFBP1 in tumor tissue fluid of patients with advanced rectal cancer
- VernacularTitle:盐酸伊立替康注射液对直肠癌晚期患者血清GPX3及肿瘤组织液WISP2、FGFBP1的影响
- Author:
Zhandong ZHANG
;
Wei YANG
;
Ye KONG
;
Ermin MA
;
Bin ZHANG
;
Ming LU
;
Yawei HUA
- Publication Type:Journal Article
- Keywords:
irinotecan;
advanced rectal cancer;
glutathione peroxidase 3;
WNT1 inducible signaling pathway protein 2;
fibroblast growth factor binding protein 1
- From:
Chinese Journal of Biochemical Pharmaceutics
2015;(8):98-100,103
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyse the effect of irinotecan hydrochloride injection on serum glutathione peroxidase 3 (GPX3), and WNT1 induced signaling pathway protein 2 (WISP2) and fibroblast growth factor binding protein 1 (FGFBP1) in tumor tissue fluid of patients with advanced rectal cancer.Methods 90 patients who were diagnosed with advanced rectal cancer in the hospital were collected.All patients were randomly divided into experimental group and control group,control group were treated with oxaliplatin +calcium folinate +fluorouracil chemotherapy, and experimental group were treated with oxaliplatin +calcium folinate +irinotecan hydrochloride injection chemotherapy.The treatment were repeated every four weeks, a total of six times.The serum GPX3 content, and WISP2, FGFBP1 levels in tumor tissue fluid were detected in two groups pre-and post treatment.The clinical efficacy was evaluated.ResuIts Compared with control group, the serum level of GPX3 in experimental group increased significantly (P<0.05);WISP2 level in tumor tissue fluid of experimental group increased significantly (P<0.05);FGFBP1 level in tumor tissue fluid of experimental group decreased significantly ( P<0.05 ) .The total efficiency of experimental group was higher than that of control group ( 64.44%vs.42.22%;χ2 =4.46,P<0.05), and the clinical benefit rate of experimental group was significantly higher than that of control group(93.33%vs.75.56%;χ2 =5.41,P<0.05).ConcIusion The irinotecan hydrochloride injection could increased levels of serum GPX3 and WISP2 in tumor tissue fluid, reduce FGFBP1 level in tumor tissue fluid, which has good clinical curative effect.
